(±)14(15)-EET

(±)14(15)-EET

CAT N°: 50651
Price:

From 74.00 62.90

(±)14(15)-EET is a metabolite of arachidonic acid (Item Nos. 90010 | 90010.1 | 10006607) that is formed via epoxidation of arachidonic acid by cytochrome P450.{463,729} It prevents increases in leukotriene B4 (LTB4; Item No. 20110), ICAM-1, and chemokine (C-C motif) ligand 1 (CCL2) induced by oxidized LDL in primary rat pulmonary artery endothelial cells (RPAECs) when used at a concentration of 1 ?M.{60003} (±)14(15)-EET induces dilation of preconstricted isolated canine coronary arterioles (EC50 = 0.2 pM).{12606} It reduces myocardial infarct size as a percentage of the area at risk in a canine model of ischemia-reperfusion injury induced by left anterior descending coronary artery (LAD) occlusion when administered at a dose of 0.128 mg/kg prior to occlusion or reperfusion.{60004}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • (±)14(15)-epoxy-5Z,8Z,11Z-eicosatrienoic acid
  • Correlated keywords
    • CYP 450 B 4 CCL 2 ICAM1
  • Product Overview:
    (±)14(15)-EET is a metabolite of arachidonic acid (Item Nos. 90010 | 90010.1 | 10006607) that is formed via epoxidation of arachidonic acid by cytochrome P450.{463,729} It prevents increases in leukotriene B4 (LTB4; Item No. 20110), ICAM-1, and chemokine (C-C motif) ligand 1 (CCL2) induced by oxidized LDL in primary rat pulmonary artery endothelial cells (RPAECs) when used at a concentration of 1 ?M.{60003} (±)14(15)-EET induces dilation of preconstricted isolated canine coronary arterioles (EC50 = 0.2 pM).{12606} It reduces myocardial infarct size as a percentage of the area at risk in a canine model of ischemia-reperfusion injury induced by left anterior descending coronary artery (LAD) occlusion when administered at a dose of 0.128 mg/kg prior to occlusion or reperfusion.{60004}

We also advise you